Opinion on Millar et al., 'Are meticillin-resistant Staphylococcus aureus bloodstream infection targets fair to those with other types of healthcare-associated infection or cost-effective?'.
Duerden
B
B
Department of Health, London, UK. brian.duerden@dh.gsi.gov.uk
D016470:Bacteremia / Q000517:prevention & control*; D003428:Cross Infection / Q000145:classification / Q000517:prevention & control; D026690:Ethics, Clinical; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D017053:Infection Control / Q000191:economics / Q000379:methods; D016106:Methicillin Resistance; D013203:Staphylococcal Infections / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects*; D006113:United Kingdom